Benicar remains on the market despite an FDA investigation, scientific studies proving its risks, and millions paid in settlements. Benicar, a hypertension medication, has been sold in the U.S. by Daiichi Sankyo since 2002. Its active ingredient, olmesartan, has been linked to celiac symptoms since 1965. Physicians who saw hypertension patients experiencing gastrointestinal symptoms
Mass Tort Blog
Smart intake practices can make all the difference in your firm’s success.
You may not realize it, but intake mistakes could be causing potential revenue to slip through your fingers.
Here are the top five most common intake mistakes costing firms money and how you can avoid them — and convert more leads into clients.
Serving more clients and boosting your bottom line in the process are great reasons to get into mass torts. But mass tort lawsuits are complicated, expensive, and high risk. That’s why a business mindset is critical to your success. At every stage of the process, from strategic planning to maximizing your return to executing your
On Friday, September 18, 2020, the American legal community lost a trailblazing, pioneering, brilliant legal mind and voice with the death of Supreme Court Associate Justice Ruth Bader Ginsburg. As a law firm, it is fitting that we acknowledge her loss and recognize her contributions. While people can disagree on whether they support her positions
Recipe for Injury and Death Combine: 1 multi-billion-dollar international corporation 1 dangerous product 400,000 customers each year in the U.S. alone 1 weak regulatory agency Many missed opportunities to disclose the dangers Bake: For a decade or so. Yield: Hundreds of cancer diagnoses and a big, fat product liability MDL. The company is Allergan, and they truly
New York’s Roman Catholic Diocese of Rockville Centre — the largest diocese in the U.S. — has filed for Chapter 11 bankruptcy protection, seeking relief from a torrent of lawsuits filed after the state suspended the statute of limitations for suing over sexual abuse by priests.
When it comes to a mass tort practice, marketing is a totally different animal from what you have experienced in your typical personal injury practice. While many lawyers cringe at the idea of advertising, marketing determines the difference between those who rise to the top and those who stagnate in the daily grind. And while